Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
WADA lists BPC-157 as prohibited at all times for governed athletes in the S0-Non-Approved Substance category
Greg Smith, CEO of IP Group, said: "As Metsera advances its portfolio, IP Groups shareholders are positioned to benefit, primarily through sustainable royalty income, should these therapies achieve approval and commercial momentum. Link to the press release in the comments
Key InformationActive Ingredient: Each tablet contains Minoxidil 2.5 mg.Uses: The primary use is the treatment of male and female pattern hair loss by promoting blood flow to hair follicles
Topical Concentrations Common Range: 0.1%-2% GHK-Cu in serums and creams for general skin use or hair and scalp application
Stacking Guide Stacks Well With Recovery peptide protocol Read the BPC-157 protocol guide Mechanism, dosing, non-response rates, the angiogenesis question, WADA status, and the 503A pathway
Not D64.9
US$ 26.81
US$ 29.85
US$ 22.42
US$ 29.82
US$ 25.73
US$ 24.91
US$ 25.02
US$ 27.65